The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(2-(((S)-1-(((S)-1-(1H-imidazol-4-yl)-3-oxopropan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)amino)-2-oxoethyl)octanamide ID: ALA5287352
Chembl Id: CHEMBL5287352
Max Phase: Preclinical
Molecular Formula: C25H35N5O4
Molecular Weight: 469.59
Associated Items:
Names and Identifiers Canonical SMILES: CCCCCCCC(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C=O)Cc1c[nH]cn1
Standard InChI: InChI=1S/C25H35N5O4/c1-2-3-4-5-9-12-23(32)27-16-24(33)30-22(13-19-10-7-6-8-11-19)25(34)29-21(17-31)14-20-15-26-18-28-20/h6-8,10-11,15,17-18,21-22H,2-5,9,12-14,16H2,1H3,(H,26,28)(H,27,32)(H,29,34)(H,30,33)/t21-,22-/m0/s1
Standard InChI Key: QOQJVJROCYJTFE-VXKWHMMOSA-N
Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 469.59Molecular Weight (Monoisotopic): 469.2689AlogP: 1.84#Rotatable Bonds: 16Polar Surface Area: 133.05Molecular Species: NEUTRALHBA: 5HBD: 4#RO5 Violations: 0HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski): 0CX Acidic pKa: 12.04CX Basic pKa: 6.54CX LogP: 1.59CX LogD: 1.54Aromatic Rings: 2Heavy Atoms: 34QED Weighted: 0.22Np Likeness Score: -0.08
References 1. Di Micco S, Rahimova R, Sala M, Scala MC, Vivenzio G, Musella S, Andrei G, Remans K, Mammri L, Snoeck R, Bifulco G, Di Matteo F, Vestuto V, Campiglia P, Márquez JA, Fasano A.. (2022) Rational design of the zonulin inhibitor AT1001 derivatives as potential anti SARS-CoV-2., 244 [PMID:36332548 ] [10.1016/j.ejmech.2022.114857 ]